-
November 15, 2012
Following the third quarter earnings release, we are maintaining our long-term 'Neutral' recommendation on DexCom ...
-
November 12, 2012
The healthcare sector is considered to be a safe haven in times of economic uncertainty as its goods and services ...
-
November 09, 2012
Covidien plc. (COV), a large-cap medical technology company, reported its adjusted earnings per share (from ...
-
November 09, 2012
On Thursday, the major U.S. stock indices fell for the second day in a row with the S&P 500 moving below its 200-day ...
-
November 08, 2012
SurModics Inc.'s (SRDX) fourth quarter fiscal 2012 earnings (excluding special items) of 19 cents per share beat the ...
-
November 07, 2012
CooperSurgical, a part of The Cooper Companies (COO), a company focused on contact lens and women's health, recently ...
-
November 07, 2012
Can Endo reestablish itself as a quality healthcare name?
-
November 06, 2012
Dendreon Corporation (DNDN) reported third quarter 2012 adjusted loss of 86 cents per share, wider than the Zacks ...
-
November 05, 2012
Vertex Pharmaceuticals Inc. (VRTX) posted break-even (including stock-based compensation expense) results in the ...
-
November 05, 2012
Dendreon has made progress with its expenses, but the sluggish revenue growth is still the major problem.
-
November 05, 2012
DexCom (DXCM), a player in the glucose monitoring market, reported third quarter 2012 loss per share of 25 cents, ...
-
November 05, 2012
A Republican White House victory could help these stocks.
-
November 05, 2012
Alkermes plc (ALKS) reported earnings of 3 cents per share (including depreciation and stock-based compensation ...
-
October 31, 2012
Renowned medical devices maker CR Bard (BCR) recently announced a definitive agreement to purchase leading thoracic ...
-
October 30, 2012
Following the release of third quarter 2012 results, most of the analysts providing estimates for Johnson & Johnson ...
-
October 26, 2012
Greatbatch, Inc.'s (GB) third-quarter 2012 adjusted earnings per share of 46 cents beat the Zacks Consensus Estimate ...
-
October 26, 2012
Merck & Co. (MRK) reported third quarter 2012 earnings per share (excluding special items) of 95 cents, a couple of ...
-
October 25, 2012
Merck & Co. Inc. (MRK) is set to announce its second quarter 2012 results on July 27, 2012, before the opening bell. ...
-
October 25, 2012
Celgene Corporation's (CELG) third quarter 2012 earnings (excluding special items but including stock-based ...
-
October 25, 2012
Elan Corporation's (ELN) loss of 5 cents per share (excluding special items) for the second quarter of 2012 was ...
